Investors

Date	Name	Title	Type	Shares Traded	Price Range
Sep 6, 2012	baker charles a	Director	Automatic Sell	13,714	150.00
Apr 17, 2012	baker charles a	Director	Automatic Sell	2,090	125.00
Apr 19, 2012	baker charles a	Director	Automatic Sell	12,910	125.00
Feb 20, 2009	baker charles a	Director	Automatic Sell	10,000	18.16
Feb 15, 2008	baker charles a	Director	Automatic Sell	10,000	18.67 - 19.06
Jul 1, 2011	baker charles a	Director	Automatic Sell	11,000	55.94 - 57.40
Jul 1, 2011	brown michael s	Director	Automatic Sell	25,000	55.89 - 56.45
Apr 18, 2011	brown michael s	Director	Automatic Sell	5,000	49.00
Mar 30, 2011	brown michael s	Director	Automatic Sell	1,691	44.35
Mar 31, 2011	brown michael s	Director	Automatic Sell	3,309	44.65
Jan 18, 2011	brown michael s	Director	Automatic Sell	4,845	34.88
Jan 19, 2011	brown michael s	Director	Automatic Sell	5,155	35.59 - 35.60
Mar 9, 2011	brown michael s	Director	Automatic Sell	6,906	39.35 - 40.00
Mar 10, 2011	brown michael s	Director	Automatic Sell	3,094	39.09
Oct 6, 2010	brown michael s	Director	Automatic Sell	3,235	29.05
Oct 7, 2010	brown michael s	Director	Automatic Sell	1,765	28.03
Dec 20, 2010	brown michael s	Director	Automatic Sell	2,103	32.89 - 33.24
Dec 17, 2010	brown michael s	Director	Automatic Sell	2,897	32.44
Jan 17, 2008	brown michael s	Director	Automatic Sell	200	25.00
Jan 22, 2008	brown michael s	Director	Automatic Sell	9,800	25.00
Showing 381-400 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.